Bayer Consumer Care AG media enquiries should be directed to:
Bayer Consumer Care AG
PR & Communications
Peter Merian Strasse 84, P.O. Box
4002 Basel, Switzerland
Email: pr-bccag [at] bayer.com
People react differently to medicines and the active substances they contain. This is why it is not possible to identify all the possible side effects of a product while it is under development, not even in the most comprehensive clinical trials. However, it is of the utmost importance for patient and drug safety (pharmacovigilance) to record side effects of all kinds, no matter how often they may occur in absolute figures.
Patient and drug safety is eminently important for Bayer as a globally operating pharmaceutical company and goes well beyond mere compliance with global regulations and requirements. No matter whether you are a customer, a patient or a healthcare professional, your support is vital in ensuring that Bayer can provide up-to-date information about the safety of its products.
If you want to report a side effect, please contact your doctor or pharmacist or the Regional Pharmacovigilance Centre, or send an e-mail to drug.safety.switzerland [at] bayer.ch. You can also use our electronic reporting system (external link). If you want to report a quality problem, please contact your doctor, pharmacist, druggist or Swissmedic, or send an e-mail to quality.switzerland [at] bayer.com.